<DOC>
	<DOCNO>NCT01804153</DOCNO>
	<brief_summary>Evaluate feasability security autologous ASC femenine stress urinary incontinence</brief_summary>
	<brief_title>Stem Cells Tratment Local Feminine Stress Urinary Incontinence Treatment ( HULPURO )</brief_title>
	<detailed_description>Evaluate safety adipose derived stem cell femenine urinary incontinence local application</detailed_description>
	<mesh_term>Urinary Incontinence</mesh_term>
	<mesh_term>Enuresis</mesh_term>
	<mesh_term>Urinary Incontinence , Stress</mesh_term>
	<criteria>1 . Signed inform consen 2 . Good general state health accord finding ythe clinical history physical examination 3 . Postmenopausal 18 year old woman take highly effective contraceptive follow ICH ( M3 ) EMA guide 4 . Women reject de rehabilitation treatment treatment fail 5 . Genuine combine stress urinary incontinence diagnose least 1 year evolution 1 . Pregnant lactate woman 2 . Active urine infection 3 . Presenting infravesical obstruction 4 . Alcohol addictive substance abuse antecedent previous 6 month inclusion 5 . Presenting malignant neoplasia unless basocellar skin epidermoide carcinoma present antecedent malignant tumour , unless remission phase previous 5 year 6 . Cardiopulmonar illness , investigator opinion , could unstable could serious enough drop patient study 7 . Any kind medical psychiatric illness , investigator opinion , could reason exclude patient study 8 . Subjects congenital aquired inmunodeficiencies , B and/or C Hepatitis , Tuberculose Treponema diagnose moment inclusion 9 . Anesthesic allergy 10 . Major surgery severe trauma previous 6 month 11 . Administration drug experimentation present 3 month recruitement</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2013</verification_date>
	<keyword>Feminine stress urinary incontinence</keyword>
	<keyword>Autologous expand stem cell</keyword>
</DOC>